Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Bain Capital and Smith Hill Capital Form $1bn Joint Venture
Bain Capital Special Situations (“Bain Capital”) and Smith Hill Capital (“Smith Hill”), an affiliate of Procaccianti Companies, today announced the formation of a joint venture to originate debt and preferred equity to serve the financing needs of companies and assets...
Alpine Investors Closes $3.4bn Deal to Support Apex Service Partners Growth
Alpine Investors (“Alpine”), a Certified B Corp people-driven private equity firm committed to building enduring software and services companies, today announced the completion of a $3.4bn single-asset secondary market transaction to continue its partnership with Apex...
KKR Secures $2.3bn Unitranche Loan to Recapitalize PetVet
KKR & Co. has reached a deal with a group of private credit lenders led by Blue Owl Capital Inc. that will help it recapitalize its portfolio company PetVet Care Centers, according to people with knowledge of the matter. The private equity firm has received a new...




